JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.)
SEPARATE ACCOUNTS A, N, S, U, AND UV
JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
SEPARATE ACCOUNT B
Supplement dated May 28, 2025 to the Statutory Prospectuses,
Updating Summary Prospectuses, and Initial Summary Prospectuses,
dated April 28, 2025
Changes to Variable Investment Options
This Supplement is intended for distribution with the Statutory Prospectuses, Updating Summary Prospectuses, and Initial Summary Prospectuses, as applicable, (each a “prospectus”) dated April 28, 2025 for variable life insurance contracts issued by John Hancock Life Insurance Company (U.S.A.) and John Hancock Life Insurance Company of New York, as applicable. The affected prospectuses belong to the following policies:
| Accumulation Survivorship Variable Universal Life 2020 |
Majestic Variable Universal Life 98 | |
| Accumulation SVUL |
Majestic VCOLIX | |
| Accumulation Variable Universal Life |
Majestic VULX | |
| Accumulation Variable Universal Life 08 |
Medallion Executive Variable Life | |
| Accumulation Variable Universal Life 2014 |
Medallion Executive Variable Life II | |
| Accumulation Variable Universal Life 2019 |
Medallion Executive Variable Life III | |
| Accumulation Variable Universal Life 2021 |
Medallion Variable Universal Life Edge | |
| Accumulation Variable Universal Life 2021 Core |
Medallion Variable Universal Life Edge II | |
| Accumulation Variable Universal Life 2025 |
Medallion Variable Universal Life Plus | |
| Accumulation Variable Universal Life 2025 Employer Market |
Performance Executive Variable Life | |
| Corporate VUL |
Performance Survivorship Variable Universal Life | |
| Corporate VUL 05 |
Protection SVUL | |
| Corporate VUL 08 |
Protection Variable Universal Life | |
| Majestic Accumulation Variable Universal Life 2019 |
Protection Variable Universal Life 09 | |
| Majestic Accumulation Variable Universal Life 2021 |
Protection Variable Universal Life 2012 | |
| Majestic Performance Survivorship Variable Universal Life |
Protection Variable Universal Life 2017 | |
| Majestic Performance Variable Universal Life |
Protection Variable Universal Life 2021 | |
| Majestic Survivorship Variable Universal Life 2020 |
Protection Variable Universal Life 2023 | |
| Majestic Survivorship VULX |
Simplified Life | |
| Majestic Variable COLI |
Variable Estate Protection | |
| Majestic Variable Estate Protection |
Variable Estate Protection Edge | |
| Majestic Variable Estate Protection 98 |
Variable Estate Protection Plus | |
| Majestic Variable Universal Life |
Variable Master Plan Plus |
Portfolio Subadvisor Change
Effective on or about May 28, 2025 (the “Effective Date”), the Small Cap Opportunities Trust’s subadvisor will be updated as indicated below:
| Former Subadvisor | New Subadvisor | |
|
Dimensional Fund Advisers LP and GW&K |
Dimensional Fund Advisers LP | |
|
Investment Management, LLC |
As a result, after the Effective Date, all references in the prospectuses to the Former Subadvisor are changed to the New Subadvisor, respectively.
Changes to Current Expenses
On or about the Effective Date, there is a reduction in “Current Expenses” for the JHVIT Small Cap Opportunities Trust in the “Appendix: Portfolios Available Under the Contract” section of the prospectus.
Accordingly, the subadvisor and “Current Expenses” of the JHVIT Small Cap Opportunities Trust Series NAV portfolio are deleted in the “Appendix: Portfolios Available Under the Contract” section of each prospectus and replaced with the following:
| Investment Objective | Portfolio and Adviser/Subadviser | Current Expenses |
Average Annual Total Returns (as of 12/31/24) (%) | |||||||
| 1-Year | 5-Year | 10-Year | ||||||||
| To seek long-term capital appreciation. |
Small Cap Opportunities Trust – Series NAV |
0.81%* | 8.64 | 10.73 | 8.55 | |||||
* This portfolio’s annual expenses reflect temporary fee or expense waivers or reimbursements.
You should read this supplement together with the prospectus for the contract you purchased and retain both documents for future reference.
Prior to making any investment decisions, you should carefully review your product prospectus and all applicable supplements. In addition, you should review the prospectuses and applicable supplements for the underlying portfolios that we make available as investment options under the policies. The prospectuses describe the investment objectives, policies and restrictions of, and the risks relating to, investment in the portfolios. In the case of any of the portfolios that are operated as feeder funds, you should also review the prospectus for the corresponding master fund. If you need to obtain additional copies of any of these documents, please contact your representative or contact our Service Office at the address or telephone number on the back page of your product prospectus.
VLI ProdSupp VL 05/2025
| 333-85284 | 333-233647 | 333-131134 | 333-238712 | 333-164162 | ||||||||||||
| 333-124150 | 333-233648 | 333-132905 | 333-126668 | 333-164164 | ||||||||||||
| 333-131299 | 333-236446 | 333-141693 | 333-152409 | 333-164163 | ||||||||||||
| 333-141692 | 333-236447 | 333-148992 | 333-164150 | 333-164165 | ||||||||||||
| 333-148991 | 333-248502 | 333-151631 | 333-164151 | 333-164166 | ||||||||||||
| 333-151630 | 333-254210 | 333-152407 | 333-164152 | 333-164167 | ||||||||||||
| 333-152406 | 333-254211 | 333-152408 | 333-164153 | 333-164168 | ||||||||||||
| 333-153252 | 333-265436 | 333-153253 | 333-164156 | 333-164169 | ||||||||||||
| 333-157212 | 333-266659 | 333-157213 | 333-164154 | |||||||||||||
| 333-179570 | 333-281927 | 333-179571 | 333-164155 | |||||||||||||
| 333-193994 | 333-281928 | 333-193995 | 333-164171 | |||||||||||||
| 333-194818 | 333-127543 | 333-235396 | 333-164173 | |||||||||||||
| 333-217721 | 333-131139 | 333-235397 | 333-164161 |